Search results
Showing 1426 to 1440 of 1688 results for carers
New Alzheimer's treatment donanemab does not currently demonstrate value for the NHS says NICE
More evidence is needed on the clinical and cost-effectiveness of donanemab, a new treatment for mild Alzheimer’s disease.
Colorectal cancer (metastatic) - MABp1 (after previous treatment) [ID917]
Discontinued [GID-TA10065]
Optical Coherence Tomography to guide percutaneous coronary intervention
In development [GID-IPG10394] Expected publication date: TBC
Aumolertinib for untreated EGFR mutation-positive non-small-cell lung cancer [ID4000]
In development [GID-TA10899] Expected publication date: TBC
Human Growth Hormone for Idiopathic Short Stature (in children)[ID317]
Discontinued [GID-TA11256]
Aflibercept solution for injection for treating wet age‑related macular degeneration (TA294)
Evidence-based recommendations on aflibercept solution for injection (Eylea) for treating wet age-related macular degeneration in adults.
This guideline covers the circumstances for inducing labour, methods of induction, assessment, monitoring, pain relief and managing complications. It aims to improve advice and care for pregnant women who are thinking about or having induction of labour.
NICE has developed a medtech innovation briefing (MIB) on 24/7 EEG SubQ for epilepsy .
Masitinib for previously treated moderate Crohn's disease [ID1239]
Discontinued [GID-TA11188]
Exploratory work regarding the use of bevacizumab in the treatment of eye conditions [ID422]
Discontinued [GID-TA11205]
Ovarian (epithelial), fallopian, peritoneal cancer - paclitaxel (encapsulated in XR-17 [ID565]
Discontinued [GID-TA11209]
Multiple myeloma (untreated) - carfilzomib (with melphalan and prednisone) [ID1133]
Discontinued [GID-TA11210]
In development [GID-TA11455] Expected publication date: TBC
Bempegaldesleukin with nivolumab for untreated unresectable or metastatic melanoma
Discontinued [GID-TA10970]
Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653]
In development [GID-TA10555] Expected publication date: TBC